1.High RNA accumulation in Candida tropicalis is affected by specific growth rate and different medium composition
Zhong LIN ; Zhongqiu LUO ; Jie DOU ; Hui WANG ; Weiran QIU ; Jing CAO ; Changlin ZHOU
Journal of China Pharmaceutical University 2011;42(2):169-175
Batch and continuous fermentation were adopted to investigate the effect of specific growth rate and amino acid components on RNA accumulation in Candida tropicalis ATCC 20408 in fermentation medium ( FM), yeast peptone dextrose medium (YPD), molasses fermentation medium ( MFM) and FM without corn steep liquor. The data showed that obvious differences in intracellular RNA accumulation were observed at different cell growth phases in bath fermentation prosess, and RNA level reached 11. 8% (g-RNA /g-DCW) during exponential phase, and only 6.9% during stationary phases. It was also found that intracellular RNA accumulation increased with the increase of specific growth rate in continue fermentation prosess, and the highest RNA level reached 15. 6% with the glucose conversion rate of 42. 8% at the dilution rate of 0. 5 h-1. Furthermore, the data showed that RNA lever was notably increased in batch fermentation process when amino acids or peptone was added into the fermentation medium containing no corn steep liquor. Taken together, it was reported for the first time that specific growth rate and amino acid components plays a leading role on the intracellular RNA accumulation in C. tropica lis, and specific growth rate is more important.
3.Clinical Efficacy of Chinese Medicine Combined with Indirect Moxibustion Plaster on COVID-19 Patients During Recovery Period Based on COVID-19 Diagnosis and Treatment Protocol(Tenth Edition)
Qiqi YANG ; Shouliang MA ; Tianxin JIANG ; Weiwei WU ; Xinyu HAN ; Weiran LI ; Shuaihui QIU ; Xinhua ZHOU ; Fei LI
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(13):96-103
ObjectiveTo observe the clinical efficacy of Chinese medicine combined with indirect moxibustion plaster on corona virus disease 2019 (COVID-19) patients during recovery period. MethodNinety patients of COVID-19 during the recovery period were randomly divided into a Chinese medicine group, an indirect moxibustion plaster group, and a combination group,with 30 cases in each group. According to the 10th edition of COVID-19 Diagnosis and Treatment Protocol,patients in the Chinese medicine group received oral Chinese medicine based on syndrome differentiation,one dose per day, twice a day. Patients in the indirect moxibustion plaster group were treated with indirect moxibustion plaster at Zusanli (ST 36), Pishu (BL 20), Dazhui (GV 14), Feishu (BL 13), Kongzui (LU 6), and Tiantu (CV 22),once a day,40 min each time. Patients in the combination group were treated with Chinese medicine combined with indirect moxibustion plaster. Treatment lasted two weeks. Before and after treatment,the traditional Chinese medicine (TCM) symptom score,pulmonary computed tomography (CT) score,St. George's Respiratory Questionnaire (SGRQ) score,blood routine indexes [white blood cell count (WBC),neutrophil count (NEUT),and lymphocyte count (LYM)], and inflammatory indexes [C-reactive protein (CRP),serum ferritin, and interleukin-6 (IL-6)] were observed in the three groups. The clinical efficacy was evaluated. ResultAfter treatment,the scores of TCM symptoms,pulmonary CT, and SGRQ,CRP,IL-6,and ferritin in the three groups decreased(P<0.05),while WBC and LYM increased(P<0.05), but there was no significant difference in NEUT. The above indexes in the combination group were better than those in the other two groups(P<0.05). After treatment, the cured and markedly effective rate was 76.7% (23/30) in the combination group, 50.0% (15/30) in the Chinese medicine group, and 46.7% (14/30) in the indirect moxibustion plaster group. The cured and markedly effective rate of the combination group was significantly higher than that of the Chinese medicine group (χ2=4.593, P<0.05) and the indirect moxibustion plaster group (χ2=5.711, P<0.05). The total effective rate was 96.7 % (29/30) in the combination group, 93.3% (28/30) in the Chinese medicine group, and 86.7% (26/30) in the indirect moxibustion plaster group. The total effective rate of the combination group was higher than that of the Chinese medicine group and the indirect moxibustion plaster group, but the differences were not statistically significant. ConclusionChinese medicine combined with indirect moxibustion plaster can effectively improve the clinical symptoms,promote pulmonary inflammation,blood routine indexes, and inflammatory indexes, and improve the quality of life of COVID-19 patients during the recovery period,which is more advantageous than Chinese medicine alone or indirect moxibustion plaster.